The program focuses on "critical importance of self-care."

Des observations indiquent qu’une forte proportion des patients touchés par la COVID-19 présentent des atteintes au cœur et aux vaisseaux sanguins.

A new research published in the journal Heart suggested that the age at which a woman's periods stop, and the menopause starts, doesn't seemed to be associated

In Poland, the mortality due to cardiovascular diseases (CVD) is still high and the burden of CVD and diabetes is also high.

W Polsce śmiertelność z powodu chorób sercowo-naczyniowych (CSN) jest nadal wysoka; również podwyższona jest częstotliwość występowania CSN i cukrzycy.

Norge har lykkes i å redusere dødeligheten forårsaket av hjerte- og karsykdommer.

Norway has been successful at reducing the mortality due to cardiovascular diseases (CVD).

The United States has been successful at reducing the mortality due to cardiovascular diseases (CVD) but the burden of CVD and diabetes is increasing rapidly.

Rising levels of obesity and diabetes around the world could halt a trend of decreasing mortality rates for cardiovascular diseases, such as strokes and heart attacks, and even cause rates to start rising again, particularly among younger people, according to a new OECD report.

Australia has been successful at reducing the mortality due to cardiovascular diseases. The mortality from cardiovascular diseases (CVD) has decreased over the past 50 years at a faster pace than the OECD average, reaching 208 per 100 000 population, 30% lower than the OECD average of 299 in 2011.

Japan has been successful at reducing the mortality due to cardiovascular diseases (CVD) but there is room to reduce the burden of CVD and diabetes even more.

日本は心疾患による死亡率を減少させるのに成功したが、心疾患と糖尿病の負担をさらに減らす余 地は残されている

The Love Island star has been trying her luck on E4's Celebs Go Dating. But the 27-year-old may not need to look much further after she was spotted with newly single Strictly Come Dancing pro.

Jessica Wright has decided that it's time to talk about the incident, as she admitted that the pair 'hadn't seen each other since we split. [She] didn’t choose to bump into him that night.'

The RuPaul's Drag Race star, 51, and the professional dancer, 29, became the latest couple to be eliminated from the series on Sunday with Giovanni saying he 'loved every single second'.

Cham : Springer, [2019]

Cham : Springer, c2019.

Vecchiato, Giovanni, author

Rotch Library - N7660.A57 2018

Hayden Library - PQ7797.B635 Z6728 2014

Online Resource

Dewey Library - HM846.S56 2020

Barker Library - QC176.8.N35 C43 2013

Browsery P279.B64 2018

Online Resource

Online Resource

Online Resource

STACK SCORE Mu pts D735 chamu

Online Resource

Online Resource

Online Resource

Online Resource

Hayden Library - Q175.5.S3234 2018

Online Resource

Mathematica has released positive evaluation findings from Year 2 of the Million Hearts® model, just in time for American Heart Month this February.

This cohort study assesses whether long-term variability and rate of change of blood pressure from young adulthood to midlife are associated with cardiovascular disease and all-cause mortality by middle age.

In this issue of JAMA Cardiology, Lim and colleagues report on cardiovascular functional reserve in people with end-stage renal disease before and after kidney transplant. They performed a 3-arm, prospective, concurrent cohort study to assess change in cardiovascular functional reserve after kidney transplant using state-of-the-art cardiopulmonary exercise testing (CPET). They also assessed left ventricular morphologic findings 1 year after transplant. They enrolled 81 participants with stage 5 chronic kidney disease (CKD) who underwent kidney transplant, 85 wait-listed participants with stage 5 CKD who had not undergone transplant, and 87 controls treated for hypertension only. The authors quantified cardiovascular functional reserve using CPET in parallel with transthoracic echocardiography. One year after transplant, a significant improvement in maximum oxygen consumption was found in the transplant group compared with the nontransplant group. Moreover, left ventricular function improved but not the body mass index.

To the Editor We read the recent article by Klauser et al with great interest. While the potential implications of the findings are exciting, we have several concerns. First, the authors do not explicitly state whether electrocardiogram gating was used in their study. This is an important detail because cardiac motion artifact is a source of artifactual coloration with dual-energy computed tomography (DECT), particularly with dual-source scanners given the approximately 80-millisecond temporal difference between the 2 radiography beams. Furthermore, beam hardening artifact from calcified atheromas and partial volume effect, known sources of artifacts in the 2-material decomposition algorithm of DECT, may largely explain the findings. While patients with gout had higher prevalence of coronary calcification (55 of 59 patients [93%]) and cardiovascular monosodium urate (MSU) deposition (51 of 59 patients [86%]) than controls, the authors do not report whether the 4 patients with gout without coronary calcifications exhibited MSU deposition nor the number of controls or cadaveric hearts with coronary calcification. The images from the article show areas of green pixelization occurring adjacent to calcified plaques on grayscale computed tomography images (eg, Figure 2A and D, left anterior descending artery [yellow arrowhead]), which would favor this artifact hypothesis without additional data.

In Reply We appreciate the valuable comments of Becce et al on our article. We applied prospective electrocardiography gating using a thin-slice cardiac protocol to ensure highest spatial resolution with minimal motion artifact. A noncontrast electrocardiography-gated computed tomography (CT) examination with standardized scan parameters was performed using a 128-slice dual-source CT (SOMATOM Definition Flash; Siemens) with a detector collimation of 2 × 64 × 0.6 mm, rotation time of 0.28 seconds, and prospective electrocardiography triggering for heart rates less than 65 beats per minute (diastolic padding, 70% of RR interval) and more than 65 beats per minute (systolic padding, 40% of RR interval). Axial images were reconstructed with 0.75-mm slice width, increment of 0.5, and a medium-smooth convolution kernel (B26f). When motion artifact was present, it was distinguished by visual analysis of an experienced observer and colorized pixels related to motion were excluded.

This cohort study assesses cardiovascular functional reserve before and after kidney transplant in patients with end-stage renal disease.

Lowering low-density lipoprotein cholesterol (LDL-C) levels remains a mainstay of cardiovascular disease prevention, but gaps in treatment remain, even in persons with hypercholesterolemia and greatly elevated LDL-C levels. Although well-described gene variants in the apolipoprotein B (APOB), low-density lipoprotein receptor (LDLR), and proprotein convertase subtilisin/kexin type 9 (PCSK9) genes explain small but important fractions of monogenic hypercholesterolemia, recent attention has turned to prognostication of cardiovascular disease using polygenic risk scores (PRS) that incorporate common genetic variants derived from large-scale genome-wide association studies of lipid subfractions. Earlier PRS considered only variants with genome-wide significance, and newer studies have focused on methods that better capture the variance conferred by millions of variants, suggesting an ability to identify risk equivalent to monogenic mutations. There remains a gap in evidence from prospective observational studies or treatment trials regarding the appropriate placement of PRS in risk assessment and lipid treatment decisions relative to information on rare monogenic gene variants, particularly in multiethnic populations.

This cohort study uses the UK Biobank cohort data to compare the association of monogenic vs polygenic hypercholesterolemia with the risk of atherosclerotic cardiovascular disease among individuals with comparable levels of low-density lipoprotein cholesterol.